论文部分内容阅读
生长抑素14肽(下称生长抑素)已广泛用于临床,有关其治疗急性胰腺炎的报道较多,但是对比研究其治疗急性水肿型、出血坏死型胰腺炎效果的报道在国内少见。本研究通过采用传统方法与生长抑素治疗上述两种病理类型的胰腺炎,旨在证实生长抑素的确切疗效及为临床用药提供理论依据。1
Somatostatin 14 peptide (hereinafter referred to as somatostatin) has been widely used in clinical, its treatment of acute pancreatitis is more reported, but comparative study of its treatment of acute edema, hemorrhagic necrotizing pancreatitis is rarely reported in the country. The purpose of this study is to confirm the exact effect of somatostatin and to provide a theoretical basis for clinical use of drug by using the traditional method and somatostatin in the treatment of pancreatitis of the above two pathological types. 1